SHLD2P1: A Protein Involved in A Variety of Cellular Processes and Potential Drug Target

Target Name: SHLD2P1

NCBI ID: G414241

SHLD2P1

SHLD2P1: A Protein Involved in A Variety of Cellular Processes and Potential Drug Target

SHLD2P1 (bA38L15.1) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the SHLD2 family, which is known for its role in intracellular signaling pathways. While the exact function of SHLD2P1 is not yet fully understood, research has shown that it is involved in a variety of cellular processes, including cell adhesion, migration, and survival.

One of the most promising aspects of SHLD2P1 is its potential as a drug target. SHLD2P1 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In addition, its unique expression pattern has led to the possibility that it may serve as a biomarker for certain diseases.

One of the ways that SHLD2P1 is being targeted as a drug is through its role in the development of neurodegenerative diseases. Alzheimer's disease is a well-known example of such a disease, and it is thought to be caused by the buildup of beta-amyloid plaques in the brain. Studies have shown that SHLD2P1 is expressed in the brains of people with Alzheimer's disease and that inhibiting its activity may be a potential treatment for the disease.

Another potential application of SHLD2P1 as a drug target is its role in cancer. Many studies have shown that SHLD2P1 is expressed in various types of cancer, including breast, ovarian, and prostate cancer. In addition, research has suggested that SHLD2P1 may play a role in the development and progression of cancer by promoting the growth and survival of cancer cells.

In addition to its potential as a drug target, SHLD2P1 has also been shown to be involved in a variety of other cellular processes. For example, studies have shown that SHLD2P1 is involved in cell adhesion and that it may play a role in the regulation of cell signaling pathways. In addition, SHLD2P1 has been shown to be involved in the regulation of cell death, which is a critical process for the survival of all living organisms.

Overall, SHLD2P1 is a protein that is expressed in a variety of tissues and is involved in a wide range of cellular processes. While its exact function is not yet fully understood, its potential as a drug target and as a biomarker for various diseases makes it an intriguing target for research and development. As research continues to advance, it is likely that the full potential of SHLD2P1 will be revealed and its applications will continue to grow.

Protein Name: Shieldin Complex Subunit 2 Pseudogene 1

The "SHLD2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHLD2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets